Tradestie Institutional Equity Comparison Engine
AORT vs UFPT โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
UFPT Overall Edge
UFPT Captures Institutional Edge (4โ0 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to UFP Technologies Inc (UFPT) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, AORT trades at 35.5x Forward P/E with 7.6% operating margin (+9.2% YoY revenue) versus UFPT at 24.7x Forward P/E and 15.4% operating margin (+11.6% YoY). In options structure, AORT sits in BREAKDOWN (20th %ile IV; Dealer Gamma Walls on Pro) against UFPT sits in UNCLASSIFIED (3rd %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
UFPT
AORT 35.5x vs UFPT 24.7x Fwd P/E
Growth & Margin Winner
UFPT
Op Margin 7.6% vs 15.4% ยท YoY +9.2% vs +11.6%
Momentum & Technical Winner
UFPT
1Y -59.5% vs +27.4% ยท 52W Pos 1% vs 74%
Options & Structure Winner
UFPT
BREAKDOWN (20th %ile IV) vs UNCLASSIFIED (3rd %ile IV)
AORT
NYSE
Artivion, Inc.
Surgical & Medical Instruments & Apparatus
$18.47
-3.3% 1D
Market Cap
$931.9M
1M Return
-15.2%
1Y Return
-59.49%
Forward P/E
35.5x
Unified AI Score
45.4 / 100
HOLD
Tech 33.0
Fund 51.0
Flow 64.0
Mom 64.0
UFPT
NASDAQ
UFP Technologies Inc
Surgical & Medical Instruments & Apparatus
$298.54
-2.14% 1D
Market Cap
$2.4B
1M Return
+2.36%
1Y Return
+27.42%
Forward P/E
24.7x
Unified AI Score
42.6 / 100
HOLD
Tech 25.0
Fund 37.0
Flow 50.0
Mom 40.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
AORT -59.49%
UFPT +27.42%
Spread: +86.91 pp (UFPT Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
AORT TTM Op. Margin: 7.6%
UFPT TTM Op. Margin: 15.4%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AORT vs UFPT. Trailing 12-month operating profitability (AORT 7.6% vs UFPT 15.4%) and valuation multiples (AORT 35.5x vs UFPT 24.7x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | AORT | UFPT | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $931.9M | $2.4B | Larger Scale | UFPT |
| Trailing P/E Ratio Valuation | 46.1x | 31.2x | Lower Multiple | UFPT |
| Forward P/E Ratio Valuation | 35.5x | 24.7x | Lower Multiple | UFPT |
| Revenue Growth (YoY) Growth | +9.2% | +11.6% | Higher Growth | UFPT |
| Operating Margin (TTM) Profitability | 7.6% | 15.4% | Higher Margin | UFPT |
| Net Profit Margin Profitability | -3.6% | 11.8% | Higher Margin | UFPT |
| Return on Equity (ROE) Capital Efficiency | -4.0% | 17.2% | Higher ROE | UFPT |
| 52-Week Range Position Momentum | 1% ($18โ$48) | 74% ($174โ$342) | Stronger Trend | UFPT |
| Beta / 30D Volatility Risk Regime | 0.45ฮฒ ยท 92% Vol | 1.64ฮฒ ยท 77% Vol | Lower Realized Risk | UFPT |
| Unified Institutional Score Composite Signal | 45.4 / 100 (HOLD) | 42.6 / 100 (HOLD) | Higher Composite | AORT |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full AORT vs UFPT Buy Guide
AORT
BREAKDOWN
65d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
20th %ile
IV Regime
Compressed (<25th %ile)
UFPT
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
3rd %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither AORT nor UFPT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.